专利信息

Translation Company

首页 1 2 尾页共 14 条记录, 当前第1/2页。

专利标题：PROCESSES FOR PREPARING SUBSTANTIALLY PURE PANTOPRAZOLE MAGNESIUM

专利标题：AMORPHOUS AND CRYSTALLINE FORMS OF PANTOPRAZOLE MAGNESIUM SALT

专利权人：TEVA PHARMA [IL];

专利标题：PROCESSES FOR PREPARING SUBSTANTIALLY PURE PANTOPRAZOLE MAGNESIUM

Provided are processes for preparing substantially pure pantoprazole magnesium. A mixture of pantoprazole acid, a magnesium base (in particular alkoxides) in an alcohol is prepared and an organic solvent is added to precipitate the pantoprazole magnesium.

专利标题：Process for preparing known pantoprazole sodium sesquihydrate

专利权人：TEVA PHARMA [IL];

Crystalline pantoprazole sodium Forms II, IV, V, VI, VIII, IX, X, XI, XII, XIII, XIV, XV, XVI, XVIII, XIX and XX;pantoprazole sodium solvates containing water, acetone, butanol, methylethylketone, dimethylcarbonate, propanal and 2-methylpropanol;and amorphous pantoprazole sodium are disclosed.

专利标题：Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole

专利权人：TEVA PHARMA [IL];

专利标题：PROCESS FOR PREPARING 2-[(PYRIDINYL)METHYL]SULFINYL-SUBSTITUTED BENZIMIDAZOLES AND NOVEL CHLORINATED DERIVATIVES OF PANTOPRAZOLE.

专利权人：TEVA PHARMA [IL];

The present invention provides a process comprising admixing a thioether with about 1.05 to about 1.6 molar equivalents of an active chlorine-containing oxidant, preferably sodium hypochlorite, and about 2.5 to about 5.0 molar equivalents of an alkali metal base;and recovering a sulfoxide that is preferably pantoprazole, lansoprazole, omeprazole, or rabeprazole. The process may further comprise contacting the sulfoxide with a source of sodium ions, preferably sodium hydroxide, to produce the sod...

专利标题：PROCESS FOR PREPARING 2-(PYRIDINYL)METHYL SULFINYL-SUBSTITUTED BENZIMIDAZOLES AND NOVEL CHLORINATED DERIVATIVES OF PANTOPRAZOLE

专利权人：TEVA PHARMA [IL];

专利标题：CRYSTALLINE AND AMORPHOUS SOLIDS OF PANTOPRAZOLE AND PROCESSES FOR THEIR PREPARATION

专利权人：TEVA PHARMA [IL];

专利标题：PROCESS FOR PREPARING 2-[(PYRIDINYL)METHYL]SULFINYL-SUBSTITUTED BENZIMIDAZOLES AND NOVEL CHLORINATED DERIVATIVES OF PANTOPRAZOLE

专利权人：TEVA PHARMA [IL];

当前查询条件: [专利权人] 包含 'TEVA PHARMA [IL]' AND [药品] 包含 'Pantoprazole'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. EP1960388A1	2008/8/27	EP20070839975	2007/11/5
专利标题：PROCESSES FOR PREPARING SUBSTANTIALLY PURE PANTOPRAZOLE MAGNESIUM 专利权人：TEVA PHARMA [IL];TEVA PHARMA [US];

2. EP1954691A2	2008/8/13	EP20070796071	2007/6/12
专利标题：AMORPHOUS AND CRYSTALLINE FORMS OF PANTOPRAZOLE MAGNESIUM SALT 专利权人：TEVA PHARMA [IL];

3. WO2008057559A1	2008/5/15	WO2007US23438	2007/11/5
专利标题：PROCESSES FOR PREPARING SUBSTANTIALLY PURE PANTOPRAZOLE MAGNESIUM 专利权人：TEVA PHARMA [IL];TEVA PHARMA [US];HEDVATI LILACH [IL];PILARSKI GIDEON [IL]; Provided are processes for preparing substantially pure pantoprazole magnesium. A mixture of pantoprazole acid, a magnesium base (in particular alkoxides) in an alcohol is prepared and an organic solvent is added to precipitate the pantoprazole magnesium.

4. EP1795530A1	2007/6/13	EP20070004220	2003/12/19
专利标题：Process for preparing known pantoprazole sodium sesquihydrate 专利权人：TEVA PHARMA [IL]; Crystalline pantoprazole sodium Forms II, IV, V, VI, VIII, IX, X, XI, XII, XIII, XIV, XV, XVI, XVIII, XIX and XX;pantoprazole sodium solvates containing water, acetone, butanol, methylethylketone, dimethylcarbonate, propanal and 2-methylpropanol;and amorphous pantoprazole sodium are disclosed.

5. CN1839127A	2006/9/27	CN20048022239	2004/6/10
专利标题：Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole 专利权人：TEVA PHARMA [IL];

6. MXPA05013316A	2006/3/17	MX2005PA13316	2005/12/7
专利标题：PROCESS FOR PREPARING 2-[(PYRIDINYL)METHYL]SULFINYL-SUBSTITUTED BENZIMIDAZOLES AND NOVEL CHLORINATED DERIVATIVES OF PANTOPRAZOLE. 专利权人：TEVA PHARMA [IL]; The present invention provides a process comprising admixing a thioether with about 1.05 to about 1.6 molar equivalents of an active chlorine-containing oxidant, preferably sodium hypochlorite, and about 2.5 to about 5.0 molar equivalents of an alkali metal base;and recovering a sulfoxide that is preferably pantoprazole, lansoprazole, omeprazole, or rabeprazole. The process may further comprise contacting the sulfoxide with a source of sodium ions, preferably sodium hydroxide, to produce the sod...

7. EP1615913A2	2006/1/18	EP20040755278	2004/6/10
专利标题：PROCESS FOR PREPARING 2-(PYRIDINYL)METHYL SULFINYL-SUBSTITUTED BENZIMIDAZOLES AND NOVEL CHLORINATED DERIVATIVES OF PANTOPRAZOLE 专利权人：TEVA PHARMA [IL];

8. EP1601667A2	2005/12/7	EP20040720431	2004/3/12
专利标题：CRYSTALLINE AND AMORPHOUS SOLIDS OF PANTOPRAZOLE AND PROCESSES FOR THEIR PREPARATION 专利权人：TEVA PHARMA [IL];

9. WO2004111029A2	2004/12/23	WO2004US19001	2004/6/10
专利标题：PROCESS FOR PREPARING 2-[(PYRIDINYL)METHYL]SULFINYL-SUBSTITUTED BENZIMIDAZOLES AND NOVEL CHLORINATED DERIVATIVES OF PANTOPRAZOLE 专利权人：TEVA PHARMA [IL];TEVA PHARMA [US];LIEBERMAN ANITA [IL];SINGER CLAUDE [IL];RAIZI YURIY [IL]; The present invention provides a process comprising admixing a thioether with about 1.05 to about 1.6 molar equivalents of an active chlorine-containing oxidant, preferably sodium hypochlorite, and about 2.5 to about 5.0 molar equivalents of an alkali metal base

10. CA2528993A1	2004/12/23	CA20042528993	2004/6/10
专利标题：PROCESS FOR PREPARING 2-[(PYRIDINYL)METHYL]SULFINYL-SUBSTITUTED BENZIMIDAZOLES AND NOVEL CHLORINATED DERIVATIVES OF PANTOPRAZOLE 专利权人：TEVA PHARMA [IL]; The present invention provides a process comprising admixing a thioether wit h about 1.05 to about 1.6 molar equivalents of an active chlorine-containing oxidant, preferably sodium hypochlorite, and about 2.5 to about 5.0 molar equivalents of an alkali metal base

下载范围

下载内容